HDAC8 and acute myeloid leukemia: revealed a novel resistance pathway involving FLT3-ITDmut: in AML cells, FLT3-ITDmut upregulates HDAC8, thereby promoting the persistence of FLT3-ITDmut AML cells even in the presence of an FLT3 inhibitor (25).